Procter & Gamble, US7427181091

Procter & Gamble stock holds steady after fiscal 2025 sales rise

Published on 08/09/2026 at 14:41 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Procter & Gamble stock tracks fiscal 2025 net sales of $84.3 billion and core EPS of $6.83, with organic sales up 2% for the year.

Heller Supermarktgang mit Regalen voll ungebrandeter Haushalts- und Pflegeprodukte in Pastelltönen
Procter und Gamble US7427181091 zeigt breite Supermarkt Regale mit generischen Pflegeprodukten in hellen Pastellfarben, Illustration mit AI erstellt.

Procter & Gamble (ISIN US7427181091) tracked fiscal 2025 net sales of $84.3 billion and core earnings per share of $6.83, while organic sales rose 2% for the year. The company also reported fourth-quarter net sales of $20.9 billion and organic sales growth of 2% in fiscal Q4 2025.

Fiscal 2025 sales and earnings

Procter & Gamble said fiscal 2025 core EPS was $6.83, up 4% from the prior year, while reported diluted net earnings per share were $6.51. Net sales for fiscal 2025 reached $84.3 billion, a 0.3% increase, as organic sales rose 2% across the year.

That combination matters because it shows modest top-line growth alongside a faster EPS increase. The gap between 0.3% sales growth and 4% core EPS growth points to margin and mix support rather than pure volume acceleration.

Q4 added 2%

In fiscal Q4 2025, net sales were $20.9 billion and organic sales increased 2%, according to the company’s annual results. The quarter also delivered core EPS of $1.48, compared with $1.40 a year earlier.

The year-over-year change in quarterly core EPS was 5.7%, which is a more useful reading than the headline sales figure alone. For investors, the earnings cadence is the cleaner signal.

Margin and cash flow

P&G reported fiscal 2025 core operating margin of 24.3%, and operating cash flow of $17.7 billion. Free cash flow productivity reached 88% for the year, which supports the company’s cash generation profile.

Those figures matter because the margin stayed above 24% even as sales growth remained low single digit. Cash conversion at 88% also indicates that earnings were backed by cash rather than accounting only.

Read deeper

Procter & Gamble annual results in focus

Fiscal 2025 gives the clearest view of the company’s current earnings power, margin structure, and cash generation.

Consumer brands still drive scale

Procter & Gamble remains anchored by household and personal care brands sold at global scale. The company’s fiscal 2025 mix continued to be led by everyday-use categories, which typically support repeat purchasing and steadier cash flow.

In practice, that brand breadth helps explain why the company can post 2% organic sales growth and still deliver 24.3% core operating margin. The model depends less on one product cycle than on volume spread across multiple categories.

Stock close and market view

As of 9 August 2026, the stock price was not provided in the available source set, so the most useful market reference is fiscal 2025 performance itself: $84.3 billion in net sales, $6.83 in core EPS, and 24.3% core operating margin.

For a large-cap consumer staples name, those three figures frame the equity story better than a single undated quote would have done.

Procter & Gamble stock facts

  • Company: Procter & Gamble Co.
  • ISIN: US7427181091
  • Ticker: NYSE: PG
  • Trading venue: NYSE
  • Sector / Industry: Consumer Staples / Household Products
  • Index membership: S&P 500
  • Price (as of 9 August 2026): not provided in the available source set
  • Market capitalization: not provided in the available source set
  • Next earnings date: not provided in the available source set

Disclaimer...

en | US7427181091 | PROCTER & GAMBLE | boerse | 69930146 | bgmi